Current stage -Stage IV - Page 16 of 44 Posts on Medivizor
Navigation Menu

Current stage -Stage IV Posts on Medivizor

FOLFIRI plus aflibercept in the treatment of metastatic colorectal cancer outside of clinical trials

FOLFIRI plus aflibercept in the treatment of metastatic colorectal cancer outside of clinical trials

Posted by on Mar 29, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of the combined treatment FOLFIRI with aflibercept (Zaltrap) outside of clinical trials in patients with metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that this treatment might be a safe second line option in patients who progressed after first-line...

Read More

Looking for men with newly diagnosed advanced prostate cancer to test treatment combinations

Looking for men with newly diagnosed advanced prostate cancer to test treatment combinations

Posted by on Mar 28, 2019 in Prostate cancer | 0 comments

In a nutshell This trial is examining the effectiveness of radical prostatectomy, in newly diagnosed advanced prostate cancer. The main outcome to be measured will be survival without the cancer worsening. This trial is recruiting in the United States. The details Androgens can cause the growth of prostate cancer cells. Antiandrogen therapy (ADT) may...

Read More

Evaluating a radionuclide treatment for metastatic castration-resistant prostate cancer

Evaluating a radionuclide treatment for metastatic castration-resistant prostate cancer

Posted by on Mar 26, 2019 in Prostate cancer | 0 comments

In a nutshell This study investigated the effectiveness of a radionuclide (RN), [¹??Lu]-PSMA-617, to treat metastatic castration-resistant prostate cancer (mCRPC) that has worsened after standard treatments. They found that this treatment was safe and effective for these patients. Some background Prostate cancer (PC) affects the...

Read More

Looking for patients with lung cancer to test a new drug

Looking for patients with lung cancer to test a new drug

Posted by on Mar 26, 2019 in Lung cancer | 0 comments

In a nutshell This phase 2 trial will investigate the safety and effectiveness of tisotumab vedotin (TTV) for the treatment of solid tumors. The main outcome will be the response rate to treatment. This trial will take place in the United States, France, and Italy. The details Non-small cell lung cancer (NSCLC) is caused by excessive cell growth in...

Read More

Safety of nivolumab and radiation therapy in patients with NSCLC that has spread

Safety of nivolumab and radiation therapy in patients with NSCLC that has spread

Posted by on Mar 19, 2019 in Lung cancer | 0 comments

In a nutshell This study evaluated the safety of nivolumab (Opdivo) combined with radiation therapy for patients with advanced non-small cell lung cancer (NSCLC) that has spread. This study found that radiation therapy before or after treatment with nivolumab was not associated with an increased risk of severe side effects. Some background...

Read More

Looking for men with prostate cancer, resistant to male hormone suppression, to be treated with medication and radiotherapy

Looking for men with prostate cancer, resistant to male hormone suppression, to be treated with medication and radiotherapy

Posted by on Jan 20, 2019 in Prostate cancer | 0 comments

In a nutshell This study evaluates the effectiveness of medication and focal radiation in the treatment of prostate cancer resistant male hormone suppression. The main outcome to be measured in this trial is the number of patients whose cancer does not grow or spread and who are alive at 18 months after treatment. This trial is taking place in Ann...

Read More

Alectinib vs crizotinib in treating brain or spinal cord tumors in patients with non-small cell lung cancer

Alectinib vs crizotinib in treating brain or spinal cord tumors in patients with non-small cell lung cancer

Posted by on Jan 12, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out which medication is better for treating lung cancer that has spread to the brain or spinal cord, crizotinib (Xalkori) or alectinib (Alecensa). The study found that alectinib worked better than crizotinib for treatment of tumors of the brain and spinal cord. Some background Alectinib and crizotinib are two...

Read More

Adding everolimus to endocrine therapy in patients with HER2- ER+ advanced breast cancer

Adding everolimus to endocrine therapy in patients with HER2- ER+ advanced breast cancer

Posted by on Jan 5, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if treating breast cancer with everolimus (Afintor) and endocrine therapy is better than only treating with endocrine therapy. The study found that using everolimus in addition to endocrine therapy had a significant benefit to survival in these patients. Some background Breast cancer is classified into types...

Read More